TABLE 3.

Relationship Between GLEASON Score, Biochemical, and Scan Finding (n = 125 Patients; Mean (Range) and Median)

PET/CT	Choline-Positive (n = 93)	Choline-Negative (n = 32)	P	PSMA-Positive (n = 14)	PSMA-Negative (n = 18)	P
Gleason score	7 (5–10) 7	7 (6–9) 7	>0.05	7 (6–9) 7	7 (6–9) 7	>0.05
PSA level (ng/mL)	7.42 (0.22–126.59) 2.84	1.34 (0.23–4.39) 1.05	<0.001	2.01 (0.53–4.39) 1.47	1.09 (0.30–2.55) 0.74	0.054
PSA doubling time (mo)#	8.2 (0.7–51.1) 5.2	12.1 (2.1–59.6) 9.0	0.005	10.7 (2.1–19.3) 9.4	12.2 (2.4–59.6) 7.6	0.540
PSA velocity (ng/mL per year)#	10.1 (0.1–267.8) 1.4	1.0 (0.1–3.5) 0.7	<0.001	1.3 (0.2–3.5) 1.0	0.9 (0.1–2.9) 0.6	0.226

^#PSA kinetics not available in one patient.

PSA indicates prostate-specific antigen; PSMA, prostate-specific membrane antigen.